Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic.
about
Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia.Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA₂ in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development.Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence.
P2860
Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Phospholipase A2 inhibitors in ...... h moves forward in the clinic.
@en
Phospholipase A2 inhibitors in ...... h moves forward in the clinic.
@nl
type
label
Phospholipase A2 inhibitors in ...... h moves forward in the clinic.
@en
Phospholipase A2 inhibitors in ...... h moves forward in the clinic.
@nl
prefLabel
Phospholipase A2 inhibitors in ...... h moves forward in the clinic.
@en
Phospholipase A2 inhibitors in ...... h moves forward in the clinic.
@nl
P2860
P1476
Phospholipase A2 inhibitors in ...... h moves forward in the clinic.
@en
P2093
Keith E Suckling
P2860
P304
P356
10.1517/13543780903184583
P407
P577
2009-10-01T00:00:00Z